1.
Vachhani P, Mesa R, Mascarenhas J, Rampal R, Oh ST, Vannucchi AM, Fox ML, Palandri F, Passamonti F, Kiladjian J-J, Azimi M, Harrison C, Bose P. JAK inhibitor selection in challenging scenarios of myelofibrosis: a review. haematol [Internet]. 2020Sep.10 [cited 2025Dec.5];. Available from: https://haematologica.org/article/view/13005